Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and butorphanol combined with propofol for painless gastrointestinal endoscopy
ChiCTR2200057013Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of propofol, butorphanol and lidocaine (3 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Propofol consumption per minute. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
propofolbutorphanollidocaine
Beyond the preview
Go deeper on ChiCTR2200057013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057013.